GAVRETO
Dead / Abandoned — Abandoned — failure to respond (as of 23 Feb 2022)
What this means for you
This application is over — abandoned 11 Feb 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90025140
- Mark type
- Design + words
- Filed
- 29 Jun 2020
- Published for opposition
- 10 Nov 2020
- Abandoned
- 11 Feb 2022
- Attorney of record
- Timothy H. Hiebert
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Blueprint Medicines Corporation, Cambridge, MA, US
- Blueprint Medicines Corporation, Cambridge, MA, US
Prosecution history
- 23 Feb 2022 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 23 Feb 2022 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 10 Aug 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 10 Aug 2021 — FINAL REFUSAL E-MAILED
- 10 Aug 2021 — SU - FINAL REFUSAL - WRITTEN
- 26 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 May 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 May 2021 — NON-FINAL ACTION E-MAILED
- 10 May 2021 — SU - NON-FINAL ACTION - WRITTEN
- 06 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Mar 2021 — USE AMENDMENT FILED
- 06 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Mar 2021 — TEAS STATEMENT OF USE RECEIVED